Format

Send to

Choose Destination
Oncotarget. 2015 Oct 20;6(32):32279-80. doi: 10.18632/oncotarget.5443.

The cerebral cavernous malformations proteins.

Author information

1
Department of Pharmacology, Yale University School of Medicine, New Haven, CT, USA.
2
Departments of Molecular Biophysics and Biochemistry, Yale University School of Medicine, New Haven, CT, USA.

KEYWORDS:

CCM disease; signal transduction

PMID:
26356566
PMCID:
PMC4741677
DOI:
10.18632/oncotarget.5443
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Impact Journals, LLC Icon for PubMed Central
Loading ...
Support Center